Kinaxis Inc. (TSE:KXS – Get Free Report) Director John Ernest Sicard sold 24,147 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of C$167.91, for a total value of C$4,054,585.55.
Kinaxis Price Performance
Kinaxis stock opened at C$165.15 on Monday. The business’s 50-day simple moving average is C$159.29 and its 200 day simple moving average is C$155.52. The stock has a market cap of C$4.66 billion, a price-to-earnings ratio of 165.15, a P/E/G ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a 12-month low of C$132.93 and a 12-month high of C$174.25. The company has a quick ratio of 2.29, a current ratio of 1.90 and a debt-to-equity ratio of 12.40.
Kinaxis (TSE:KXS – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported C$0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of C$0.43 by C$0.04. The business had revenue of C$165.79 million for the quarter, compared to analysts’ expectations of C$170.56 million. Kinaxis had a return on equity of 4.87% and a net margin of 4.59%. As a group, research analysts anticipate that Kinaxis Inc. will post 4.2526231 earnings per share for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on Kinaxis
About Kinaxis
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Recommended Stories
- Five stocks we like better than Kinaxis
- Basic Materials Stocks Investing
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- With Risk Tolerance, One Size Does Not Fit All
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Invest in the FAANG Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.